These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 31686408)

  • 1. Risk Factors Associated with the Occurrence of Neonatal Opioid Withdrawal Syndrome: A Review.
    Kelty E; Preen DB
    CNS Drugs; 2019 Nov; 33(11):1113-1120. PubMed ID: 31686408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal Opioid Withdrawal Syndrome (NOWS): A Transgenerational Echo of the Opioid Crisis.
    Weller AE; Crist RC; Reiner BC; Doyle GA; Berrettini WH
    Cold Spring Harb Perspect Med; 2021 Mar; 11(3):. PubMed ID: 32229609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal abstinence syndrome.
    Coyle MG; Brogly SB; Ahmed MS; Patrick SW; Jones HE
    Nat Rev Dis Primers; 2018 Nov; 4(1):47. PubMed ID: 30467370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal and iatrogenic neonatal opioid withdrawal syndrome: Differences and similarities in recognition, management, and consequences.
    Isaac L; van den Hoogen NJ; Habib S; Trang T
    J Neurosci Res; 2022 Jan; 100(1):373-395. PubMed ID: 33675100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal opioid toxicity: opioid withdrawal (abstinence) syndrome with emphasis on pharmacogenomics and respiratory depression.
    Baldo BA
    Arch Toxicol; 2023 Oct; 97(10):2575-2585. PubMed ID: 37537419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.
    Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT
    JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5-8 months of age.
    Bakhireva LN; Holbrook BD; Shrestha S; Leyva Y; Ashley M; Cano S; Lowe J; Stephen JM; Leeman L
    Early Hum Dev; 2019 Jan; 128():69-76. PubMed ID: 30554024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal opioid use during pregnancy and the risk of neonatal opioid withdrawal syndrome in the offspring.
    Kristensen AW; Vestermark V; Kjærbye-Thygesen A; Eckhardt MC; Kesmodel US
    Acta Obstet Gynecol Scand; 2024 Aug; 103(8):1522-1529. PubMed ID: 38700023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gestational buprenorphine exposure: Effects on pregnancy, development, neonatal opioid withdrawal syndrome, and behavior in a translational rodent model.
    Wallin CM; Bowen SE; Roberge CL; Richardson LM; Brummelte S
    Drug Alcohol Depend; 2019 Dec; 205():107625. PubMed ID: 31706250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Care-by-parent model as a tool for reduction of neonatal opioid withdrawal syndrome in neonates exposed to buprenorphine maintenance therapy in-utero.
    Lawlor ML; Shook LA; McQuerry K; Srinivasan A; Johnson QB; Chavan NR; Critchfield AS
    J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2718-2722. PubMed ID: 30563376
    [No Abstract]   [Full Text] [Related]  

  • 11. Duration and Timing of In Utero Opioid Exposure and Incidence of Neonatal Withdrawal Syndrome.
    Wang Y; Berger L; Durrance C; Kirby RS; Kuo D; Pac J; Ehrenthal DB
    Obstet Gynecol; 2023 Sep; 142(3):603-611. PubMed ID: 37548391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between Individual versus Community-level Social Vulnerability and Neonatal Opioid Withdrawal Syndrome among Pregnant Individuals Receiving Buprenorphine for Opioid Use Disorder.
    Mason I; Abdelwahab M; Stiles A; Wu J; Venkatesh KK; Rood KM
    Am J Perinatol; 2024 May; 41(S 01):e3157-e3163. PubMed ID: 37890511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal Abstinence Syndrome: Review of Epidemiology, Care Models, and Current Understanding of Outcomes.
    MacMillan KDL
    Clin Perinatol; 2019 Dec; 46(4):817-832. PubMed ID: 31653310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome.
    Griffin BA; Caperton CO; Russell LN; Cabanlong CV; Wilson CD; Urquhart KR; Martins BS; Zita MD; Patton AL; Alund AW; Owens SM; Fantegrossi WE; Moran JH; Brents LK
    J Pharmacol Exp Ther; 2019 Jul; 370(1):9-17. PubMed ID: 31028107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newborn Cry Acoustics in the Assessment of Neonatal Opioid Withdrawal Syndrome Using Machine Learning.
    Manigault AW; Sheinkopf SJ; Silverman HF; Lester BM
    JAMA Netw Open; 2022 Oct; 5(10):e2238783. PubMed ID: 36301544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infant Mortality Associated With Prenatal Opioid Exposure.
    Leyenaar JK; Schaefer AP; Wasserman JR; Moen EL; O'Malley AJ; Goodman DC
    JAMA Pediatr; 2021 Jul; 175(7):706-714. PubMed ID: 33843963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Influence of Mediators on the Relationship Between Antenatal Opioid Agonist Exposure and the Severity of Neonatal Opioid Withdrawal Syndrome.
    Devlin LA; Hu Z; Ounpraseuth S; Simon AE; Annett RD; Das A; Fuller JF; Higgins RD; Merhar SL; Smith PB; Crawford MM; Cottrell LE; Czynski AJ; Newman S; Paul DA; Sánchez PJ; Semmens EO; Smith MC; Whalen BL; Snowden JN; Young LW;
    Matern Child Health J; 2023 Jun; 27(6):1030-1042. PubMed ID: 36905529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid Treatment for Neonatal Opioid Withdrawal Syndrome: Current Challenges and Future Approaches.
    McPhail BT; Emoto C; Butler D; Fukuda T; Akinbi H; Vinks AA
    J Clin Pharmacol; 2021 Jul; 61(7):857-870. PubMed ID: 33382111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Practical Approach to Neonatal Opiate Withdrawal Syndrome.
    Devlin LA; Davis JM
    Am J Perinatol; 2018 Mar; 35(4):324-330. PubMed ID: 29100261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severity of neonatal opioid withdrawal syndrome with prenatal exposure to serotonin reuptake inhibitors.
    Bakhireva LN; Sparks A; Herman M; Hund L; Ashley M; Salisbury A
    Pediatr Res; 2022 Mar; 91(4):867-873. PubMed ID: 34588611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.